• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Anecdotes From The Field

Anecdotes From The Field

January 1, 2005
Tom Rusk, M.D.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue
Tom Rusk, M.D. is Chief of Adult Psychiatry at Community Health & Counseling Services in Winterport, Maine. He shares his approach to minimizing the risk of SSRI-induced agitation. Dr. Rusk has disclosed that he is a member of the speakers bureau of Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Astra Zeneca, and Eli Lilly.
“Eight or nine years ago I had a couple of young adults become highly agitated and violent in the week after I started an SSRI (paroxetine in both cases). One beat up his girlfriend badly despite the lack of any history of violence previously. (I have since become dissatisfied with paroxetine because it seems to carry the worst risk of every bad side effect of SSRIs -- discontinuation syndrome, sexual side effects, fatigue, etc., with no clear benefits compared with other SSRIs.) But regarding the specific issues of violence and suicidality, I have learned to initiate any SSRI at much lower than recommended dosages in all patients: 12.5 mg sertraline, 5mg fluoxetine, 5 mg escitalopram, and so forth, in order to diminish the tendency of these medications to cause initial agitation. The vast majority of our patients have had psychiatric symptoms for months or more often years, so why not start very low and go very slow in everyone including the young, old, and medically ill? With responsible patients, I often encourage them to increase after several days if they are not experiencing any agitation. I have had almost no problem with initial agitation in adolescents or anyone else since taking this approach.”
General Psychiatry
Tom Rusk, M.D.

More from this author
www.thecarlatreport.com
Issue Date: January 1, 2005
SUBSCRIBE NOW
Table Of Contents
rTMS: Will It Replace ECT?
Antidepressant Updates: Generics, VNS, & Serzone
Dr. Michael J. Gitlin on Using the Newer Antidepressants
Thinking Outside the Box
Anecdotes From The Field
The Dual Reuptake Wars
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.